Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Genentech, Inc.
Information provided by (Responsible Party):
Retina Vitreous Associates of Florida
ClinicalTrials.gov Identifier:
NCT01476449
First received: November 13, 2011
Last updated: November 4, 2014
Last verified: November 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: September 2016
  Estimated Primary Completion Date: September 2016 (Final data collection date for primary outcome measure)